ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Oncotelic Therapeutics Inc (QB)

Oncotelic Therapeutics Inc (QB) (OTLC)

0,041
-0,0008
(-1,91%)
Fermé 05 Juillet 10:00PM

Oncotelic Therapeutics Inc (QB) (OTLC) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,041
( -1,91% )
Prix Achat
0,0369
Prix Vente
0,0504
Volume échangé
370 194
0,04 Fourchette du Jour 0,044
0,015 Plage de 52 semaines 0,11
Cap du marché
Clôture Veille
0,0418
Ouverture
0,0429
Dernière Transaction
1745
@
0.041
Dernière heure de transaction
Volume financier
US$ 15 380
VWAP
0,041545
Volume moyen (3 m)
US$ 279 480
Actions en circulation
444 497 302
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
0,07
Bénéfice par action (BPA)
0,58
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
247,38M

À propos de Oncotelic Therapeutics Inc (QB)

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing O... Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States. The company develops antisense and small molecule injectable drugs for the treatment of cancer. It is also developing OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes; OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer, melanoma, and glioblastoma, as well as for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. In addition, the company develops CA4P for the treatment of advanced metastatic melanoma; AL-101, an intranasal drug and delivery system for intra-nasal apomorphine for the treatment of parkinson’s disease, erectile disfunction, and female sexual disfunction; Artemisinin, a natural derivative from an Asian herb Artemisia Annua; and AI based technologies to enhance the development and commercialization of support technologies, as well as nanoparticle products for the treatment of various cancers. The company is based in Agoura Hills, California. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Agoura Hills, United States
Fondé
-
Oncotelic Therapeutics Inc (QB) est coté dans le secteur Healthcare de la OTC Markets avec le ticker OTLC. Le dernier cours de clôture d'Oncotelic Therapeutics (QB) était de US$0,04. Au cours de la dernière année, les actions de Oncotelic Therapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,015 à US$ 0,11.

Oncotelic Therapeutics (QB) compte actuellement 444 497 302 actions en circulation. La capitalisation boursière d'Oncotelic Therapeutics (QB) est de US$18,22 million. Oncotelic Therapeutics (QB) a un ratio cours/bénéfice (ratio PE) de 0.07.

OTLC Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.00248-5.703771849130.043480.0480.042060680.04238121CS
4-0.009-180.050.0550.042194190.04625357CS
120.004512.32876712330.03650.0620.03352787750.04520696CS
26-0.0374-47.70408163270.07840.0940.0152867720.04684383CS
52-0.00438-9.651828999560.045380.110.0152507480.06132309CS
1560.016567.34693877550.02450.110.0151809450.04573845CS
260-0.1365-76.90140845070.17750.2590.011896240.07284233CS

OTLC - Frequently Asked Questions (FAQ)

What is the current Oncotelic Therapeutics Inc (QB) share price?
The current share price of Oncotelic Therapeutics Inc (QB) is US$ 0,041
How many Oncotelic Therapeutics Inc (QB) shares are in issue?
Oncotelic Therapeutics Inc (QB) has 444 497 302 shares in issue
What is the market cap of Oncotelic Therapeutics Inc (QB)?
The market capitalisation of Oncotelic Therapeutics Inc (QB) is USD 18,22M
What is the 1 year trading range for Oncotelic Therapeutics Inc (QB) share price?
Oncotelic Therapeutics Inc (QB) has traded in the range of US$ 0,015 to US$ 0,11 during the past year
What is the PE ratio of Oncotelic Therapeutics Inc (QB)?
The price to earnings ratio of Oncotelic Therapeutics Inc (QB) is 0,07
What is the registered address of Oncotelic Therapeutics Inc (QB)?
The registered address for Oncotelic Therapeutics Inc (QB) is 29397 Agoura Road, Agoura Hills, California, 91301
What is the Oncotelic Therapeutics Inc (QB) website address?
The website address for Oncotelic Therapeutics Inc (QB) is www.oncotelic.com
Which industry sector does Oncotelic Therapeutics Inc (QB) operate in?
Oncotelic Therapeutics Inc (QB) operates in the Biotechnology & Life Sciences sector

OTLC Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock